Solutions
Mission driven science
A dedicated portfolio of impactful solutions that help prevent malaria and improve the lives of those most affected by the disease.
Core Products
Landcent’s Prevention Portfolio includes Insecticide-Treated Nets (ITNs) and antimalarial medicines designed for use in Seasonal Malaria Chemoprevention (SMC) and Perennial Malaria Chemoprevention (PMC) programmes.
Neonet™
- Dual AI bednet designed to combat and abate insecticide resistance
- High bio-efficiency that works against the most common species of resistant Anopheles mosquitoes
Neonet NG™
- Novel AI bednet designed to combat insecticide resistance
- Durability of 3 years in field use & 20 washes throughout the lifetime of the product
- High bio-efficiency that works against the most common species of Aedes & Anopheles mosquitoes
Codispaq™
- Long-term chemoprevention reducing 88% of clinical malaria
- A 3-day regimen, offering protection for 30 days, safe for children 3 months and above
- A 1-day regimen offering protection for 30 days that is safe for pregnant women
Gates Foundation on why they backed Landcent
Prioritizing Biosafety
Over 230,000 natural compounds screened in 2 years, by a team of 12 scientists, toxicology experts and laboratory staff.
- Biopesticides are usually less toxic than conventional pesticides.
- They tend to affect only the target pest, are often effective in very small quantities.
- Biopesticides generally decompose quickly.
- Complex scaffolds of natural occurring compounds would make vector resistance less likely.
AU-EU Initiative
Landcent has launched an AU-EU Research Partnership to investigate “Cochlospermum Tinctorium” for potential AIs to develop Indigenous vector control recipes.
RLS Partnership
Partnership with RLS India, to explore the use of Micelle Technology for use in treated bednets and indoor residual sprays.
SIOC Laboratory
Funded by Landcent & BMGF, the Shanghai Institute of Organic Chemistry (SIOC) has screened over 230,000 compounds from natural database libraries.
Invest with us
Landcent offers a unique, de-risked investment opportunity for impact investors to join the mission to eliminate poverty-related diseases, starting with malaria. Our collective efforts can break the vicious cycle of poverty and disease for the poorest in the world.
Sourcing for Impact
A significant part of Landcent's history has been to provide "Sourcing as a Service" for supplemental income. We reinvest these profits in research and development for our malaria products. In addition to sourcing high-quality laboratory consumables, diagnostic kits, and instruments, we also guarantee a resilient supply chain.
Read more
We work with
